Israeli biotech Oramed has reported success in the Phase IIb study of its insulin capsule. Oramed highlighted that it was the first time an oral solution showed a significant drop in blood sugar at night. Oral insulin will replace injected delayed-release insulin.
Success for diabetes treatment trial
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.